BioNTech SE (BVMF:B1NT34)

BioNTech SE Revenue

BioNTech SE had revenue of 148.50M EUR in the quarter ending March 31, 2026, a decrease of -39.24%. This brings the company's revenue in the last twelve months to 2.69B, up 4.82% year-over-year. In the year 2025, BioNTech SE had annual revenue of 3.05B with 5.63% growth.

• Revenue (ttm): 2.69B EUR
• Revenue Growth: +4.82%
• P/S Ratio: 6.72
• Revenue / Employee: 344.19K EUR
• Employees: 7,807
• Market Cap: 113.44B BRL

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.05B	162.80M	5.63%
Dec 31, 2024	2.89B	-1.03B	-26.31%
Dec 31, 2023	3.92B	-13.39B	-77.33%
Dec 31, 2022	17.31B	-1.67B	-8.78%
Dec 31, 2021	18.98B	18.49B	3,834.63%
Dec 31, 2020	482.30M	373.70M	344.11%
Dec 31, 2019	108.60M	-18.98M	-14.87%
Dec 31, 2018	127.58M	65.98M	107.11%
Dec 31, 2017	61.60M	-	-

Data Source: Fiscal.ai Last updated: Mar 31, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error